Company profile
Lumos Diagnostics Holdings Ltd.
OTC: LDXHF · Healthcare · Medical - Specialties
#604 of 1,418 Healthcare companies by revenue58th-percentile growth
EA Score
——FH —DQ —GM —SS 37
v0.1 · 5/100 weight · pillars only
↑ market scale, revenue growth (YoY) · ↓ listing tenure, return on equity
Methodology →Revenue TTM
$26.0M
Rev growth YoY (TTM)
+20.3%
Net income (FY)
-$7.2M
Employees
15
as of 2026-09-03
Market cap
$66.7M
as of 2026-09-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$12.5M$12.5M2025
Net income-$7.2M-$7.2M2025
Operating income-$7.8M-$7.8M2025
Total assets$20.8M$20.8M2025
Liabilities$14.7M$14.7M2025
Equity$6.2M$6.2M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Lumos Diagnostics Holdings Ltd.’s revenue?
Lumos Diagnostics Holdings Ltd. booked $12.5M in FY2025 revenue, growing 12% year over year — about the middle of the pack among Healthcare companies we track, at a -57.5% net margin.
Peers · Healthcare
Radnostix, Inc.51DLeveljump Healthcare Corp.——Spero Therapeutics, Inc.68BNexgenRx Inc.71BClearday, Inc.——Medical Marijuana, Inc.58CNeighbors
San Diego →Key facts
CEODouglas Ward
SectorHealthcare
IndustryMedical - Specialties
HeadquartersCarlsbad, CA
ExchangeOTC: LDXHF
Employees15
IPO date2021-09-22
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.